Bellerophon Therapeutics Inc expected to post a loss of 60  cents a share - Earnings Preview

Bellerophon Therapeutics

07/03/2022 15:13

* Bellerophon Therapeutics Inc  BLPH.OQ   BLPH.O  is
expected
to show no change in quarterly revenue when it reports 
results on March 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Bellerophon
Therapeutics
Inc is for a loss of 60 cents per share. For the same quarter
last year, the company reported a loss of 86 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $22.5​, about 91.2% above​ its last closing
price of $1.97. ​​​

This summary was machine generated March 7 at 15:13 GMT.  All
figures in US dollars  unless otherwise stated